225 related articles for article (PubMed ID: 16106097)
1. On the role of sIL-2R measurements in rheumatoid arthritis and cancers.
Witkowska AM
Mediators Inflamm; 2005 Aug; 2005(3):121-30. PubMed ID: 16106097
[TBL] [Abstract][Full Text] [Related]
2. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
3. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy.
Kirkham BW; Davison SC; Corkill MM; Barbatis C; Panayi GS
J Rheumatol; 1993 Jun; 20(6):935-9. PubMed ID: 8350327
[TBL] [Abstract][Full Text] [Related]
4. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
5. [The serum level of the secreted interleukin 2 receptor (sIL-2R): a lymphocyte activity parameter in sarcoidosis].
Müller-Quernheim J; Strausz J; Ferlinz R
Pneumologie; 1990 Feb; 44 Suppl 1():213-4. PubMed ID: 2367367
[TBL] [Abstract][Full Text] [Related]
6. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
Olejniczak K; Kasprzak A
Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
[TBL] [Abstract][Full Text] [Related]
7. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
8. [Interleukin 2 receptor--the structure, function and clinical significance in malignant diseases of adults and children].
Bień E; Balcerska A
Postepy Hig Med Dosw; 2003; 57(6):669-83. PubMed ID: 15002163
[TBL] [Abstract][Full Text] [Related]
9. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
Siemińska A
Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
[TBL] [Abstract][Full Text] [Related]
10. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis.
Crilly A; Kolta S; Dougados M; Sturrock RD; Amor B; Capell HA; Madhok R
Ann Rheum Dis; 1995 Feb; 54(2):137-9. PubMed ID: 7702403
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies].
Bień E; Balcerska A; Ciesielski D
Wiad Lek; 2006; 59(1-2):10-5. PubMed ID: 16646285
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
[TBL] [Abstract][Full Text] [Related]
14. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.
Miossec P; Elhamiani M; Edmonds-Alt X; Sany J; Hirn M
Arthritis Rheum; 1990 Nov; 33(11):1688-94. PubMed ID: 2242065
[TBL] [Abstract][Full Text] [Related]
15. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
[TBL] [Abstract][Full Text] [Related]
16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
17. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses.
Kirkham BW; Corkill MM; Davison SC; Panayi GS
J Rheumatol; 1991 Jun; 18(6):821-5. PubMed ID: 1895263
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment.
Boiardi L; Macchioni P; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
Clin Exp Rheumatol; 1994; 12(4):357-62. PubMed ID: 7955597
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis.
Timmer TC; Baltus B; Vondenhoff M; Huizinga TW; Tak PP; Verweij CL; Mebius RE; van der Pouw Kraan TC
Arthritis Rheum; 2007 Aug; 56(8):2492-502. PubMed ID: 17665400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
